employee
Hatiko Veterinary Clinic
employee
, Russian Federation
employee
Moskva, Moscow, Russian Federation
employee
employee
Moskva, Moscow, Russian Federation
employee
Moskva, Moscow, Russian Federation
employee
Moskva, Moscow, Russian Federation
GRNTI 68.41 Ветеринария
Feline enteric coronavirus (FECV) infects enterocytes and causes inflammation of the intestinal mucosa in young cats, resulting in diarrhea. In adult cats the infection is usually asymptomatic, but the constant circulation of FECV in the feline population increases the likelihood of mutation, as a result of which about 5-10% of infected cats develop a virulent strain of the virus that causes usually lethal feline infectious peritonitis – FIP. The purpose of this study was to study the effectiveness of Phosprenyl (PP), an immunomodulator with antiviral activity (active substance - polyprenyl phosphate), in the treatment of chronic coronavirus infection of cats, partially complicated by toxoplasmosis. A total of 117 cats were under observation, 10 of which also had toxoplasmosis. The diagnosis was confirmed by the determination of antibodies by the methods of IHA and ELISA, as well as by ultrasound examination of the abdominal organs. Prescribed treatment: Phosprenyl per os, 1 ml , twice a day, course 2-4 months; Gamavit daily, s/c, course 10 days, with a repeated course after 3 weeks; 3-4 times. As symptomatic therapy, drugs were used primarily to improve the condition of the stool, with toxoplasmosis - Fansidar. At the end of treatment symptoms of gastrointestinal tract damage disappeared in all the patients. If before the start of therapy, the majority of patients demonstrated changes characteristic of anemia (a significant decrease in the number of red blood cells and hemoglobin levels), then after 2-4 months, the indices of erythropoiesis completely normalized. In patients with coronavirus infection complicated by toxoplasmosis, anemia was detected by CBC test, as well as an increase in the number of neutrophils. In the biochemical profile of these patients: increased activity of the enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT) was found as well as hyperbilirubinemia, which indicates greater liver damage and a decrease in its detoxification function during the course of the disease caused simultaneously by coronavirus and toxoplasmas. At the end of therapy, these indices also returned to normal. Thus, the use of Phosprenyl for 2-4 months reduces the duration of the disease of coronavirus infection in cats (including cases complicated by toxoplasmosis), prevents its exacerbation and possible fatal outcome. Long-term use of PP in cats with a chronic form of coronavirus infection is recommended.
cats, coronavirus, phosprenyl, gamavit, gamapren, blood counts, anemia, therapy
1. Deeva, A.V. Primenenie Fosprenila dlya profilaktiki i terapii pri transmissivnom gastroenterite sviney / A.V. Deeva, R.V. Belousova, N.K. Mischenko, T.P. Lobova, L.L. Danilov, M.L. Zayceva, S.V. Ozherelkov, I.N. Bakulin, A.V. Pronin // Veterinariya. ‒ 2004. ‒ № 2. ‒ S. 12-15.
2. Deeva, A.V. Primenenie Fosprenila pri ostryh virusnyh infekciyah telyat / Deeva A.V., Rakova T.N., Lobova T.P., Nazarova A.I., Ivanov N.V., Zayceva M.L., Ozherelkov S.V., Krasota A.Yu., Bakulin I.N., Pronin A.V., Belousova R.V. // Veterinariya. ‒ 2004. ‒ № 6. ‒ S. 15-17.
3. Leonard, R.A. Ocenka effektivnosti preparata Gamavit pri korrekcii renal'noy anemii u koshek s HBP: kontroliruemoe randomizirovannoe issledovanie / Leonard R.A., Zaripova T.E., Balahonov A.N., Vdovina N.Yu., Narovlyanskiy A.N., Pronin A.V., Sanin A.V. // RVZh. ‒ 2020. ‒ № 5. ‒ S. 8-20, DOI: 10.32416/2500-4379-2020-5-8-20
4. Zhavnis, S.E. Kompleksnoe lechenie koronavirusnogo gastroenterita u kotyat: klinicheskiy sluchay / S.E. Zhavnis, I.O. Pereslegina, A.A. Sanina // Izvestiya Orenburgskogo GAU. ‒ 2019. ‒ № 5(79). ‒ S. 205-207.
5. (Narovlyanskiy A.N.) Isoprenoids: polyprenols and polyprenyl phosphates as physiologically important metabolic regulators / A.N. Narovlyansky, A.V. Pronin, A.V. Sanin et al.. New York: Nova Sci. Publishers, Inc., 2018. 177 p.
6. Ozherelkov, S.V. Eksperimental'noe issledovanie fenomena antitelozavisimogo usileniya infekcionnosti virusa kleschevogo encefalita in vitro / S.V. Ozherelkov, E.S. Kalinina, T.N. Kozhevnikova, A.V. Sanin, T.Yu. Timofeeva, A.V. Timofeev, D.R. Stivenson // Zhurnal mikrobiologii, epidemiologii i immunobiologii. ‒ 2008. ‒ № 6. ‒ S. 39-43.
7. Pereslegina, I.O. Novoe v lechenii koshach'ego infekcionnogo peritonita / I.O. Pereslegina, A.A. Videnina, A.N. Narovlyanskiy, A.V. Pronin, A.V. Sanin // RVZh. MDZh. ‒ 2013. ‒ №1. ‒ S. 6-10.
8. Pronin, A.V. Rol' citokinov v immunomoduliruyuschih effektah fosfatov poliprenolov – protivovirusnyh preparatov novogo pokoleniya / A.V. Pronin, S.V. Ozherelkov, A.N. Narovlyanskiy i dr. // Ross. immunol. zh. ‒ 2000. ‒ T. 5. ‒ № 2. ‒ S. 155–164.
9. (Pronin, A.V.) New approaches to the prevention and treatment of viral diseases / Pronin A.V., Narovlyansky A.N., Sanin A.V. // Arch Immunol Ther Exp (Warsz). ‒ 2021 Apr. ‒ Vol. 3. ‒ No. 69(1). ‒ 10 pp. DOI 10.1007/s00005-021-00613-w
10. Savoyskaya, S.L. Kontrolirovanie hronicheskoy koronavirusnoy infekcii koshek s pomosch'yu fosprenila i gamavita / S.L. Savoyskaya, I.V. Ogorodnikova, T.N. Kozhevnikova // Veterinariya i kormlenie. ‒ 2021. ‒ №3. ‒ C. 46-48. DOI: 10.30917/ATT-VK-1814-9588-2021-3-13
11. Sanin, A.V. Immunomodulyatory v veterinarnoy praktike – primenenie i protivorechiya / A.V. Sanin, A.N. Narovlyanskiy, S.V. Ozherelkov, A.V. Pronin, V.Yu. Sanina // Veterinarnaya klinika. ‒ 2008. ‒ №10. ‒ S. 10-12.
12. Sanin, A.V. Gamavit dlya korrekcii toksicheskoy gemoliticheskoy anemii i stimulyacii eritropoeza / A.V. Sanin, A.N. Narovlyanskiy, A.V. Pronin, T.N. Kozhevnikova, O.Yu. Sosnovskaya, S.E. Zhavnis, S.V. Ozherelkov, D.A. Klimova // Veterinariya. ‒ 2018. ‒ №10. ‒ S. 54-59.
13. Sanin, A.V. Fosforilirovannye poliprenoly kak universal'nye agenty podavleniya virusnoy reprodukcii / A.V. Sanin, A.V. Pronin, A.N. Narovlyanskiy, S.V. Ozherelkov, A.M. Sedov // Uspehi sovremennoy biologii. ‒ 2022. ‒ T. 142. ‒ №3. ‒ S.268-285.
14. Sanin, A.V. Issledovanie protivovospalitel'noy aktivnosti fosprenila v eksperimente / A.V. Sanin, S.A. Suhanova, O.V. Proskurina, N.M. Mitrohin, I.V Ganshina., G.F. Sud'ina, V.Yu. Sanina, A.A. Videnina, T.N. Kozhevnikova, A.A. Sanin, S.V. Ozherelkov, A.V. Salichev, A.V. Pronin, A.N. Narovlyanskiy // RVZh.MDZh. ‒ 2011. ‒ № 4. – S. 17-20.
15. Sanin, A.V. Izuchenie antioksidantnyh svoystv Fosprenila v razlichnyh biologicheskih test-sistemah / A.V. Sanin, A.N. Narovlyanskiy, A.V. Pronin, T.N. Kozhevnikova, V.Yu. Sanina, A.D. Agafonova // RVZh.MDZh. ‒ 2017. ‒ № 10. ‒ S. 28-31.
16. Sobolev, S.M. Rol' lektin-substratnogo raspoznavaniya v immunoregulyatornom vzaimodeystvii interleykina-2 i IGG / S.M. Sobolev, T.N. Nikolaeva, E.A. Grigor'eva, A.V. Pronin // Medicinskaya immunologiya. ‒ 2010. ‒ № 12(1-2). ‒ S. 13-20. https://doi.org/10.15789/1563-0625-2010-1-2-13-20
17. Furman, I.M. Primenenie preparatov na osnove rastitel'nyh poliprenolov pri razlichnyh formah koshach'ego infekcionnogo peritonita / I.M. Furman, I.K. Vasil'ev, A.N. Narovlyanskiy, A.V. Pronin, A.V. Sanin // RVZh. MDZh. ‒ 2010. ‒ №3. ‒ S. 42-43.
18. Dye, C. Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines / C. Dye, N. Temperton, S. G. Siddell, Journal of General Virology. ‒ 2007. ‒ No. 88 (6). ‒ pp. 1753–60. doi:10.1099/vir.0.82666-0
19. Flegr, J. Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study / J. Flegr // Parasites Vectors. ‒ 2021. ‒ No. 14. ‒ pp. 508. https://doi.org/10.1186/s13071-021-05021-9
20. Hartmann, K. Coronavirus Infections (Canine and Feline), including Feline Infectious Peritonitis / K. Hartmann // In: Ettinger SJ, Feldman EC, Côté E (Eds.): Textbook of Veterinary Internal Medicine. ‒ Elsevier, St. Louis, 2018, pp. 983–991.
21. Jaimes, J.A. Whittaker. Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function / Jaimes J.A., Gary R. // Virology. ‒ 2018. ‒ Vol. 517, ‒ pp, 108-121, https://doi.org/10.1016/j.virol.2017.12.027.
22. Jaimes, J.A. A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses / J.A. Jaimes, J.K. Millet, Alison E. Stout, Nicole M.A., G.R. Whittaker // Viruses. ‒ 10 January 2020. ‒ No. 12 (1). ‒ pp. 83. doi:10.3390/v12010083
23. Legendre, A.M. Polyprenyl Immunostimulant Treatment of Cats with Presumptive Non-Effusive Feline Infectious Peritonitis In a Field Study / A.M. Legendre, T. Kuritz, G. Galyon, V. Baylor, R. Heidel // Front Vet Sci. ‒ 2017. ‒ No. 14(4). ‒ pp. 7.
24. Paltrinieri, S. Association between faecal shedding of feline coronavirus and serum α1-acid glycoprotein sialylation / S. Paltrinieri, M.E.Gelain, F. Ceciliani, A.M. Ribera, M. Battilani // Journal of Feline Medicine & Surgery. ‒ 2008. ‒ No. 10 (5) ‒ pp. 514-518. doi:10.1016/j.jfms.2008.04.004
25. Pedersen, N.C. An update on feline infectious peritonitis: virology and immunopathogenesis / N.C. Pedersen // Vet. J. ‒ 2014. ‒ No. 201. ‒ pp. 123-132.
26. Regan, A.D. Utilization of DC-SIGN for Entry of Feline Coronaviruses into Host Cells / A.D. Regan, G.R. Whittaker // Journal of Virology. ‒ 2008. ‒ No. 82 (23). ‒ pp, 11992–11996. doi: 10.1128/JVI.01094-08.
27. Rottier, P.J.M. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein / P.J.M. Rottier, K. Nakamura, P. Schellen, H. Volders, B.J. Haijema // Journal of Virology. ‒ 2005. ‒ Vol. 79. ‒ No. 22. ‒ pp. 14122–14130. doi:10.1128/JVI.79.22.14122-14130.2005.
28. Stoddart, C.A. Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence / C.A. Stoddart, F.W. Scott // Journal of Virology, 1989. ‒ Vol. 63. ‒ No. 1. ‒ pp. 436-440.
29. Takano, T. Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary / T. Takano, Y. Katada, S. Moritoh et al. // J. Gen Virol. ‒ 2008. ‒ No. 89(4). ‒ pp. 1025-1029.
30. Tani, K. CD13/aminopeptidase N, a Novel Chemoattractant for T Lymphocytes in Pulmonary Sarcoidosis / K. Tani, F. Ogushi, L. Huang, T. Kawano, H. Tada, N. Hariguchi, S. Saburo // Am. J. Respir. Crit. Care Med. ‒ 2000. ‒ Vol 161. ‒ pp 1636-1642.
31. Tekes, G. Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis / G. Tekes, H.J. Thiel // 1st ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2016. Vol. 96.
32. Tresnan, D.B. Feline Aminopeptidase N is a Receptor for All Group I Coronaviruses / D.B. Tresnan, K.V. Holmes, In Enjuanes, Luis Siddell, Stuart G., Spaan Willy (eds.). The Effects of Noise on Aquatic Life. // Advances in Experimental Medicine and Biology. ‒ 1998. ‒ Vol. 730. pp. 69–75. doi:10.1007/978-1-4615-5331-1_9
33. Vlasak, R. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses / R. Vlasak, W. Luytjes, W. Spaan, P. Palese // Proc. Natl. Acad. Sci. USA. ‒ 1988. ‒ No. 85, pp. 4526-4529.
34. Wan, Y. Molecular mechanism for antibody-dependent enhancement of coronavirus entry / Y. Wan, J. Shang, S. Sun, W. Tai, J. Chen, Q. Geng, L. He, Y. Chen, J. Wu, Z. Shi, Y. Zhou, L. Du, F. Li // J Virol. ‒ 2020. ‒ No. 94. ‒ e02015-19. https://doi.org/10.1128/ JVI.02015-19.
35. Wurzer, W.J. The sialate-4-O-acetylesterases of coronaviruses related to mouse hepatitis virus: a proposal to reorganize group 2 Coronaviridae / W.J. Wurzer, K. Obojes, R. Vlasak // J. Gen. Virol. ‒ 2002. ‒ No. 83, pp. 395-402.
36. Zappulli, V. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective / V. Zappulli, S. Ferro, F. Bonsembiante, G. Brocca, A. Calore, L. Cavicchioli, C. Centelleghe, G. Corazzola, S. De Vreese, M.E. Gelain, S. Mazzariol, V. Moccia, N. Rensi, A. Sammarco, F. Torrigiani, R. Verin, M. Castagnaro // Animals. ‒ 2020. ‒ No. 10(12). ‒ pp. 2377. https://doi.org/10.3390/ani10122377
